Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 135062-02-1
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of repaglinide during breastfeeding. Repaglinide is a weak acid that is over 98% protein bound, so it is unlikely to pass into breastmilk in clinically important amounts. Monitor breastfed infants for signs of hypoglycemia such as jitteriness, excessive sleepiness, poor feeding, seizures cyanosis, apnea, or hypothermia. If there is concern, monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with repaglinide.[1] However, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
References
- 1.
- Berlin CM, Briggs GG. Drugs and chemicals in human milk. Semin Fetal Neonatal Med 2005;10:149-59 [PubMed: 15701580]
Substance Identification
Substance Name
Repaglinide
CAS Registry Number
135062-02-1
Drug Class
Breast Feeding
Lactation
Milk, Human
Hypoglycemic Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Linagliptin.[Drugs and Lactation Database (...]Review Linagliptin.. Drugs and Lactation Database (LactMed®). 2006
- Review Nateglinide.[Drugs and Lactation Database (...]Review Nateglinide.. Drugs and Lactation Database (LactMed®). 2006
- Review Pramlintide.[Drugs and Lactation Database (...]Review Pramlintide.. Drugs and Lactation Database (LactMed®). 2006
- Review Glimepiride.[Drugs and Lactation Database (...]Review Glimepiride.. Drugs and Lactation Database (LactMed®). 2006
- Review Acetohexamide.[Drugs and Lactation Database (...]Review Acetohexamide.. Drugs and Lactation Database (LactMed®). 2006
- Repaglinide - Drugs and Lactation Database (LactMed®)Repaglinide - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...